We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Revvity Guanosine 3,5-Cyclic Phosphate, Ammonium Salt
Revvity 250 µCi quantities of Guanosine 3,5-Cyclic Phosphate, Ammonium Salt, [8-3H]-, are available for your research. Radiochemical Purity is >96% - REVPFZ (Additional S&H Or Hazmat Fees May Apply)
Revvity 250 µCi quantities of [8-3H]-Guanosine 3,5-Cyclic Phosphate (cGMP), Ammonium Salt, are available for your research. Application of [3H]cGMP can be found in: binding domains of a specific phosphodiesterase in cellular signalling, interactions of mefloquine with ABC proteins (MRP1 and MRP4) in biochemical pharmacology, expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5) in pharmacology, etc. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)
Revvity Special Information: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)
- REVPFZ (Additional S&H Or Hazmat Fees May Apply)- CONVERSION TO OTHER SALTS: The ammonium salt may be converted to that of another cation by passing it through a small column of exchange resin in the form the desired cation. A 1-2mL quantity of thoroughly washed resin is generally satisfactory. Necessary precautions should be exercised to minimize any breakdown from occurring during this procedure. Removal of Solvent: An aliquot or the entire sample can be taken to dryness by directing a gentle stream of inert gas (nitrogen) over the surface of the solution. The temperature of the solution should not be allowed to exceed 20°C during the drying process, and the compound should not be permitted to remain in the solid state any longer than necessary.
| SKU | REVPFZ-NET337250UC |
|---|---|
| Supplier Part Number | NET337250UC |
| UM | PK |
| UNSPSC | 12142207 |
| Manufacturer | Revvity |
| CountryOfOrigin | United States |
| ProductLine | REVPFZ |
| Qty | 250 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 6 |
| Hazardous | Y |
| Energy Star | No |
| Green | No |
| Controlled | N |